Author: HongQun-Ying WuGuo-Ming QianGui-Sheng HuCheng-Ping ZhouJian-Ying ChenLiang-An LiWei-Min LiShi-Yue WangKai WangQi ZhangXiao-Ju LiJing GongXin BaiChun-Xue on behalf of the Lung Cancer Group of the Chinese Thoracic Society; Chinese Alliance Against Lung Cancercncr29584-cr-0002
Publisher: Blackwell Publishing
E-ISSN: 1097-0142|121|17|3080-3088
ISSN: 0008-543X
Source: Cancer, Vol.121, Iss.17, 2015-09, pp. : 3080-3088
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Optimising the management of lung cancer
Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. :
Lung cancer in China: The new frontier?
By RamalingamSuresh S. KhuriFadlo R.
Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. :
An overview of Cancer's special issue on lung cancer in China
Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. :
Novel Agents in the Management of Lung Cancer
Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. :